Wyeth Pharmaceutical's Prevnar (pneumococcal 7-valent conjugatevaccine) is now being manufactured in single-dose, prefilledsyringes.
Wyeth Pharmaceutical's Prevnar (pneumococcal 7-valent conjugate vaccine) is now being manufactured in single-dose, prefilled syringes. This new packaging will allow the vaccine to be administered directly from the syringe, thereby reducing the risk for dosing errors. The company will no longer be manufacturing the previously available vials of Prevnar vaccine. The new syringes will be sold in packages of 10.
To see more Hot off the Press news articles, click here click here.
To go to the Drug Topics homepage, click here.
Pharmacists Should Take a Proactive Approach When Addressing Controlled Substance Concerns
March 24th 2024At this year’s American Pharmacists Association Annual Meeting & Exposition, Mark Garofoli urged pharmacists to develop strong documentation practices and go beyond baseline federal regulations to care for patients with red flags.